Terms: = Lymphoma AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
25 results:
1. Healthcare resource utilization in myeloproliferative neoplasms: a population-based study from Ontario, Canada.
Bankar A; Zhao H; Iqbal J; Coxford R; Cheung MC; Mozessohn L; Earle CC; Gupta V
Leuk Lymphoma; 2020 Aug; 61(8):1908-1919. PubMed ID: 32323602
[TBL] [Abstract] [Full Text] [Related]
2. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
[No Abstract] [Full Text] [Related]
3. The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.
Ector GICG; Govers TM; Westerweel PE; Grutters JPC; Blijlevens NMA
Leuk Lymphoma; 2019 Jun; 60(6):1485-1492. PubMed ID: 30668187
[TBL] [Abstract] [Full Text] [Related]
4. Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer.
Kobayashi H; Omori S; Nakashima K; Wakuda K; Ono A; Kenmotsu H; Naito T; Murakami H; Endo M; Takahashi T
Int J Clin Oncol; 2017 Aug; 22(4):690-697. PubMed ID: 28382561
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical analysis of laryngeal non-Hodgkin's lymphoma].
Chen L; Zhang M; Li C; Zhou L; Zhu JX; Pang SY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):546-548. PubMed ID: 29871307
[No Abstract] [Full Text] [Related]
6. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
[TBL] [Abstract] [Full Text] [Related]
7. ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Marchetti A; Di Lorito A; Pace MV; Iezzi M; Felicioni L; D'Antuono T; Filice G; Guetti L; Mucilli F; Buttitta F
J Thorac Oncol; 2016 Apr; 11(4):487-95. PubMed ID: 26916631
[TBL] [Abstract] [Full Text] [Related]
8. Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic target.
Demeure MJ; Aziz M; Rosenberg R; Gurley SD; Bussey KJ; Carpten JD
World J Surg; 2014 Jun; 38(6):1296-305. PubMed ID: 24633422
[TBL] [Abstract] [Full Text] [Related]
9. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
[TBL] [Abstract] [Full Text] [Related]
10. Targeting A20 enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells.
Dong B; Lv G; Wang Q; Wei F; Bellail AC; Hao C; Wang G
Biochem Biophys Res Commun; 2012 Feb; 418(2):433-8. PubMed ID: 22285182
[TBL] [Abstract] [Full Text] [Related]
11. [Central nervous system lymphoma and its significance].
Zheng W; Lin NJ; Xie Y; Wang XP; Tu MF; Liu WP; Song YQ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1550-4. PubMed ID: 21914369
[TBL] [Abstract] [Full Text] [Related]
12. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data.
Usvasalo A; Elonen E; Saarinen-Pihkala UM; Räty R; Harila-Saari A; Koistinen P; Savolainen ER; Knuutila S; Hollmén J
Leuk Res; 2010 Nov; 34(11):1476-82. PubMed ID: 20303590
[TBL] [Abstract] [Full Text] [Related]
14. Clinical values of multiple Epstein-Barr virus (EBV) serological biomarkers detected by xMAP technology.
Gu AD; Lu LX; Xie YB; Chen LZ; Feng QS; Kang T; Jia WH; Zeng YX
J Transl Med; 2009 Aug; 7():73. PubMed ID: 19698162
[TBL] [Abstract] [Full Text] [Related]
15. Prolonged idiotypic vaccination against follicular lymphoma.
Inoges S; Lopez-Diaz de Cerio A; Zabalegui N; Soria E; Villanueva H; Panizo C; Rodriguez-Caballero A; Suarez L; Pastor F; Rodriguez-Calvillo M; Orfao A; Bendandi M
Leuk Lymphoma; 2009 Jan; 50(1):47-53. PubMed ID: 19152172
[TBL] [Abstract] [Full Text] [Related]
16. Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma.
Tracey L; Spiteri I; Ortiz P; Lawler M; Piris MA; Villuendas R
J Interferon Cytokine Res; 2004 Mar; 24(3):185-95. PubMed ID: 15035852
[TBL] [Abstract] [Full Text] [Related]
17. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.
Chessells JM; Veys P; Kempski H; Henley P; Leiper A; Webb D; Hann IM
Br J Haematol; 2003 Nov; 123(3):396-405. PubMed ID: 14616997
[TBL] [Abstract] [Full Text] [Related]
18. Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells.
Yanase N; Takada E; Yoshihama I; Ikegami H; Mizuguchi J
J Interferon Cytokine Res; 1998 Oct; 18(10):855-61. PubMed ID: 9809621
[TBL] [Abstract] [Full Text] [Related]
19. Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
Younes A; Ayoub JP; Sarris A; Hagemeister F; North L; Pate O; McLaughlin P; Rodriguez MA; Romaguera J; Kurzrock R; Preti A; Bachier C; Smith T; Cabanillas F
Br J Haematol; 1997 Feb; 96(2):328-32. PubMed ID: 9029021
[TBL] [Abstract] [Full Text] [Related]
20. Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomas.
Knauf WU; Koenigsmann MP; Notter M; Hoppe B; Reufi B; Oberberg D; Thiel E; Berdel WE
Leuk Lymphoma; 1996 Oct; 23(3-4):305-11. PubMed ID: 9031111
[TBL] [Abstract] [Full Text] [Related]
[Next]
